Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Neuro-Oncology Advances
|
November 26, 2019
Sox2<sup>+</sup> cells in Sonic Hedgehog-subtype medulloblastoma resist p53-mediated cell-cycle arrest response and drive therapy-induced recurrence
Daniel M Treisman, Yinghua Li, Brianna R Pierce, et al.
Investigative Ophthalmology & Visual Science
|
May 26, 2006
Deletion of smooth muscle alpha-actin alters blood-retina barrier permeability and retinal function
James J Tomasek, Carol J Haaksma, Robert J Schwartz, et al.
Experimental Cell Research
|
March 28, 2012
MMP-2 expression by fibroblasts is suppressed by the myofibroblast phenotype
Eric W Howard, Beverly J Crider, Dawn L Updike, et al.
The Journal of Urology
|
September 17, 2004
Decreased expression of smooth muscle alpha-actin results in decreased contractile function of the mouse bladder
R A Zimmerman, J J Tomasek, J McRae, et al.
Neoplasma
|
July 13, 2011
Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients
J Halamkova, I Kiss, Z Pavlovsky, et al.
The Journal of Investigative Dermatology
|
January 28, 2014
Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling
Jeffrey D McBride, Alicia J Jenkins, Xiaochen Liu, et al.
Neoplasma
|
December 25, 2012
Clinical impact of PAI 1 4G/5G gene polymorphism in colorectal carcinoma patients
J Halamkova, I Kiss, Z Pavlovsky, et al.
Cancer Research
|
June 12, 2016
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase
Nathaniel Weygant, Yang Ge, Dongfeng Qu, et al.
International Journal of Cancer
|
March 27, 2018
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer
Yang Ge, Nathaniel Weygant, Dongfeng Qu, et al.
Oncotarget
|
January 22, 2015
DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
Nathaniel Weygant, Dongfeng Qu, Randal May, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Neuro-Oncology Advances
|
November 26, 2019
Sox2<sup>+</sup> cells in Sonic Hedgehog-subtype medulloblastoma resist p53-mediated cell-cycle arrest response and drive therapy-induced recurrence
Daniel M Treisman, Yinghua Li, Brianna R Pierce, et al.
Investigative Ophthalmology & Visual Science
|
May 26, 2006
Deletion of smooth muscle alpha-actin alters blood-retina barrier permeability and retinal function
James J Tomasek, Carol J Haaksma, Robert J Schwartz, et al.
Experimental Cell Research
|
March 28, 2012
MMP-2 expression by fibroblasts is suppressed by the myofibroblast phenotype
Eric W Howard, Beverly J Crider, Dawn L Updike, et al.
The Journal of Urology
|
September 17, 2004
Decreased expression of smooth muscle alpha-actin results in decreased contractile function of the mouse bladder
R A Zimmerman, J J Tomasek, J McRae, et al.
Neoplasma
|
July 13, 2011
Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients
J Halamkova, I Kiss, Z Pavlovsky, et al.
The Journal of Investigative Dermatology
|
January 28, 2014
Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling
Jeffrey D McBride, Alicia J Jenkins, Xiaochen Liu, et al.
Neoplasma
|
December 25, 2012
Clinical impact of PAI 1 4G/5G gene polymorphism in colorectal carcinoma patients
J Halamkova, I Kiss, Z Pavlovsky, et al.
Cancer Research
|
June 12, 2016
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase
Nathaniel Weygant, Yang Ge, Dongfeng Qu, et al.
International Journal of Cancer
|
March 27, 2018
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer
Yang Ge, Nathaniel Weygant, Dongfeng Qu, et al.
Oncotarget
|
January 22, 2015
DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
Nathaniel Weygant, Dongfeng Qu, Randal May, et al.
Page
of 8